Shareholding disclosure

Newron Pharmaceuticals S.p.A.

Collectively declared rate

20.64%

Threshold

Crossed upwards

Timeline

Published

22.12.2012

Transaction

17.12.2012

Transfer date

21.12.2012

Voting rights breakdown

Voting rights acquired20.64%

Voting rights sold0%

Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBCCL00044

Beneficial owner

Investor AB

Declared address

Investor AB, 10332 Stockholm

lock-up of 4 months starting on 17 December 2012 applying to 80% of the shares issued to Duba AB and HealthCap Holdings KB Holdings under the transaction agreement completed on 17 December 2012 Duba AB is a wholly-owned indirect subsidiary of Investor AB

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.22.12.2012TBCCL00044

Disclosure summary

Investor AB disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 22.12.2012, at 20.64% of voting rights. The filing groups 2 beneficial owners declared together. Notice category: Group of shareholders.

Disclosed position

Collectively declared rate

2 people

20.64%

Voting rights acquired

Voting rights acquired20.64%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Declared beneficial owners · 2 people

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Disclosure detail

Investor AB disclosed a holding in Newron Pharmaceuticals S.p.A., published on 22.12.2012.

Publication date22.12.2012

Transaction date17.12.2012

Transfer date21.12.2012

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerInvestor AB

Declared addressInvestor AB, 10332 Stockholm

CategoryGroup of shareholders

Voting rights acquired20.64%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBCCL00044

Conditions

lock-up of 4 months starting on 17 December 2012 applying to 80% of the shares issued to Duba AB and HealthCap Holdings KB Holdings under the transaction agreement completed on 17 December 2012 Duba AB is a wholly-owned indirect subsidiary of Investor AB

Source: SIX Exchange Regulation · Publication date: 22.12.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open